Uriostegui-Pena AG

ORCID: 0000-0002-8303-2782 · 1 paper in corpus
2025
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph18071060

Background/Objectives: Ovarian cancer (OC) remains one of the most lethal malignancies of the female reproductive system. Glucose oxidase (GOx) has emerged as a potential therapeutic agent in cancer treatment by inducing tumor starvation th…